- For Print
- June 17, 2009
ÎÚÑ»´«Ã½. (Headquarters: Tokyo, President & CEO: Haruo Naito, “ÎÚÑ»´«Ã½”) announced today that the Company had established its new subsidiary, ÎÚÑ»´«Ã½ GesmbH (Location: Vienna, General Manager: Georg Wager, “ÎÚÑ»´«Ã½ Austria”) in Austria. ÎÚÑ»´«Ã½ Austria is a subsidiary wholly-owned by ÎÚÑ»´«Ã½ Europe Limited (Headquarters: Hatfield, UK, Chairman & CEO: Yutaka Tsuchiya, “ÎÚÑ»´«Ã½ Europe”), the European subsidiary of ÎÚÑ»´«Ã½.
ÎÚÑ»´«Ã½ entered into the Austrian market in 2005 setting up a branch of its German subsidiary ÎÚÑ»´«Ã½ GmbH (Location: Frankfurt, Managing Director: Andreas Wiegand). The Austrian branch has been marketing Zonegran® and Inovelon® for the treatment of epilepsy, Neurobloc® for cervical dystonia, Prialt® for severe chronic pain, and also collaborating in the promotion of Aricept® for Alzheimer's Disease. It has also served as a support centre for marketing, medical and regulatory affairs for the business operations in Central and Eastern Europe.
With the establishment of a subsidiary in Austria, a subsidiary wholly-owned by ÎÚÑ»´«Ã½ Europe, ÎÚÑ»´«Ã½ will strengthen its business operations in Austria and Central and Eastern European countries in preparation for future possible business expansion in this region.
ÎÚÑ»´«Ã½ currently has ten subsidiaries in Europe with the newly established ÎÚÑ»´«Ã½ Austria. ÎÚÑ»´«Ã½ will continue to strengthen its business operations in Europe and to address the diversified needs of patients and their families, thereby improving patient value.
[ÎÚÑ»´«Ã½ Austria's Outline]
*You can scroll to the left or right here
Company Name : | ÎÚÑ»´«Ã½ GesmbH |
Date of Establishment : | April 1, 2009 |
Capital : | 35 thousand euros |
Location : | Vienna, Austria |
General Manager : | Georg Wager |
Business Operations : | Sales and Promotion of Pharmaceutical Products |